0001140361-18-005181.txt : 20180205 0001140361-18-005181.hdr.sgml : 20180205 20180205201351 ACCESSION NUMBER: 0001140361-18-005181 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180201 FILED AS OF DATE: 20180205 DATE AS OF CHANGE: 20180205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davis George Eric CENTRAL INDEX KEY: 0001380710 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 18575909 MAIL ADDRESS: STREET 1: C/O BIOMARIN PHARMACEUTICAL INC. STREET 2: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2018-02-01 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001380710 Davis George Eric C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901 0 1 0 0 EVP, General Counsel Common Stock 2018-02-01 2018-02-01 4 M 0 30000 38.59 A 112942 D Common Stock 2018-02-01 2018-02-01 4 S 0 30000 90.6555 D 82942 D Stock Option (Right to buy Common Stock) 38.59 2018-02-01 2018-02-01 4 M 0 30000 0 D 2008-11-22 2018-05-21 Common Stock 30000 0 D Trade made pursuant to a 10b5-1 plan executed on June 9, 2017. The price in column 4 is the weighted average price. The price actually received ranged from $90.00 to $91.86. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. Reflects the number of options outstanding after the transactions from this specific stock option grant. /s/ Laura Randall Woodhead, Attorney-in-Fact 2018-02-05